Specialty immunoassays

Rules-Based Medicine (RBM), an IQVIA business, is a CLIA-certified biomarker testing laboratory developing immunoassays used to quantify protein biomarkers in support of drug mechanism of action, pharmacodynamic, prognostic, and predictive clinical studies across all stages of drug discovery and development.

RBM is the world’s leading multiplexed immunoassay testing laboratory that solves complex drug development challenges with innovative biomarker services and a novel whole blood immunophenotyping device (TruCulture®). RBM’s internally developed and manufactured immunoassays based on Luminex® multi-analyte profiling (MAP) and single-molecule array (Simoa®) ultrasensitive immunoassay technology provides translational and clinical researchers with reproducible and quantitative data for a few or hundreds of human proteins. RBM’s newest platform is Olink®, which uses proximity extension assay (PEA) technology to deliver optimal specificity with the scalability of high-throughput, multiplex protein biomarker analysis.

Learn more at rbm.iqvia.com. 

 The comprehensive menu provides extensive coverage of numerous pathways and delivers accurate pharmacodynamic and safety assessments. RBM’s CLIA certified biomarker testing laboratory is located in Austin, TX.

Rules-Based Medicine has  spent more than 20 years internally developing and manufacturing multiplex immunoassays validated to clinical laboratory standards for the Luminex xMAP® technology. Since 2014, RBM has also developed ultrasensitive immunoassays on the Simoa platform to quantify protein biomarkers previously difficult or impossible to measure. The RBM platform appropriately combines  microsphere-based immunoassays with the precision and dependability of automated liquid handling systems, advanced quality monitoring, validated data reporting processes, and a highly trained and dedicated staff including project managers with significant lab experience. Together, these features set RBM apart from other biomarker testing laboratories by providing the highest quality, cost-effective approach to measuring biomarkers from a variety of biological samples.

Why Choose Rules-Based Medicine for your Clinical Trial?

• Extensive experience of developing, validating, and manufacturing immunoassays allows us to provide customers with unmatched expertise in the field of protein biomarker testing.
• Quality control measures in place for each and every step of the process, all in accordance with their strict standard operating procedures.
• Four-step quality control procedures including instruments diagnostics, calibrator curves at front and back end of each reaction plate, three levels of controls run in duplicate, and sample review.
• TruCulture® – an integrated whole-blood collection and leukocyte culture system tube for immunophenotyping.